Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

cisatracurium besylate

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

cisatracurium besylate Quick Finder

HIGHLIGHTS OF PRESCRIBING INFORMATION

These highlights do not include all the...
Did you find an answer to your question? Yes No

1 INDICATIONS AND USAGE

Cisatracurium Besylate Injection is indicated:

  • as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of...
Did you find an answer to your question? Yes No

2 DOSAGE AND ADMINISTRATION

2.1 Important Dosage and Administration Instructions

Important administration instructions include:

  • Cisatracurium...
Did you find an answer to your question? Yes No

3 DOSAGE FORMS AND STRENGTHS

Cisatracurium Besylate Injection, USP injection is available as a clear solution in the following strengths:

  • 10 mg of cisatracurium per 5 mL (2 mg/mL) in single-dose vials...
Did you find an answer to your question? Yes No

4 CONTRAINDICATIONS

Cisatracurium Besylate Injection is contraindicated in patients with known hypersensitivity to cisatracurium. Severe anaphylactic reactions to Cisatracurium Besylate Injection have been reported...

Did you find an answer to your question? Yes No

5 WARNINGS AND PRECAUTIONS

5.1 Residual Paralysis

Cisatracurium Besylate Injection has been associated with residual paralysis. Patients with neuromuscular diseases (...

Did you find an answer to your question? Yes No

6 ADVERSE REACTIONS

6.1 Clinical Studies Experience

Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the...

Did you find an answer to your question? Yes No

7 DRUG INTERACTIONS

7.1 Clinically Significant Drug Interactions

Table 4 displays clinically significant drug interactions with Cisatracurium Besylate Injection.

...
Did you find an answer to your question? Yes No

8 USE IN SPECIFIC POPULATIONS

8.1 Pregnancy

Risk Summary

There are no adequate...

Did you find an answer to your question? Yes No

10 OVERDOSAGE

Overdosage with neuromuscular blocking agents may result in neuromuscular blockade beyond the time needed for surgery and anesthesia. The primary treatment is maintenance of a patent airway and controlled...

Did you find an answer to your question? Yes No

11 DESCRIPTION

Cisatracurium besylate is a nondepolarizing skeletal neuromuscular blocker for intravenous administration. Compared to other neuromuscular blockers, it is intermediate in its onset and duration of action....

Did you find an answer to your question? Yes No

12 CLINICAL PHARMACOLOGY

12.1 Mechanism of Action

Cisatracurium besylate binds competitively to cholinergic receptors on the motor end-plate to antagonize the action...

Did you find an answer to your question? Yes No

13 NONCLINICAL TOXICOLOGY

13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility

...

Did you find an answer to your question? Yes No

14 CLINICAL STUDIES

14.1 Skeletal Muscle Relaxation for Intubation of Adult Patients

The efficacy of Cisatracurium Besylate Injection to provide skeletal muscle...

Did you find an answer to your question? Yes No

16 HOW SUPPLIED/STORAGE AND HANDLING

Cisatracurium besylate injection, USP is a clear solution supplied as follows:

Cisatracurium Besylate Injection, USP, 2 mg cisatracurium per mL, is supplied in the following:

...
Did you find an answer to your question? Yes No

17 PATIENT COUNSELING INFORMATION

Hypersensitivity Reactions Including Anaphylaxis

Advise the caregiver and/or family that severe...

Did you find an answer to your question? Yes No

Distributed by Hospira, Inc., Lake Forest, IL 60045 USA

logo

LAB-1269-4.0...

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event